News

Bivalirudin edges unfractionated heparin for PCI in acute coronary syndrome patients


 

AT ACC 15

References

MATRIX was an investigator-initiated study that received grant support from Terumo and the Medicines Co. Dr. Valgimigli had no disclosures. Dr. Jolly has been a consultant to AstraZeneca, a speaker on behalf of St. Jude, and received research grants from Medtronic. Dr. Kandzari has been a consultant to Medtronic and Boston Scientific and has received research support from Abbott Vascular, Biotronik, Boston Scientific, and Medtronic. Dr. Grines has been a consultant to and received honoraria from Abbott Vascular, the Medicines Co., Merck, and the Volcano Group.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Coordinated regional STEMI care delivers dividends
MDedge Emergency Medicine
VIDEO: Focused cardiac ultrasound aids acute heart failure patients
MDedge Emergency Medicine
Takotsubo cardiomyopathy: predicting in-hospital mortality
MDedge Emergency Medicine
Unnecessary stress tests in ED leading to overdiagnosis
MDedge Emergency Medicine
Lower bleeding, death risk with fondaparinux after NSTEMI
MDedge Emergency Medicine
NSAIDs after MI raise bleeding risk
MDedge Emergency Medicine
Women having heart attacks face longer prehospital delay
MDedge Emergency Medicine
SCOT-HEART: CT angiography scores big in stable chest pain
MDedge Emergency Medicine
VIDEO: Data support switching to transradial PCI access
MDedge Emergency Medicine
Advanced age no barrier to aggressive heart attack treatment
MDedge Emergency Medicine